Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Gastric Ulcers Market?

In the past few years, the size of the gastric ulcers market has robustly expanded. Anticipated to escalate from $4.29 billion in 2024 to $4.53 billion in 2025, the market is projected to progressively grow at a compound annual growth rate (CAGR) of 5.6%. The expansion in the historic era is generally credited to the surge in helicobacter pylori infections cases, amplified utilization of nonsteroidal anti-inflammatory drugs (NSAIDs), mounting global geriatric populace, escalating campaigns promoting gastric ulcer prevention, and a rise in stress-related disorder incidents.

The market size of gastric ulcers is predicted to experience substantial growth over the coming years, reaching $5.55 billion in 2029 with a compound annual growth rate (CAGR) of 5.2%. This predicted growth over the forecast period can be ascribed to advancements in diagnostic methodologies, the increasing prevalence of unhealthy eating habits, progression in therapeutic alternatives inclusive of proton pump inhibitors (PPIs), an aging population leading to an escalated disease load, and the evolution of healthcare systems in up-and-coming markets. Notable developments anticipated during the forecast period comprise a shift towards combination therapies for increased effectiveness, a growing inclination toward minimally invasive treatment methods, the incorporation of digital health strategies in disease control, an escalating need for over-the-counter (OTC) ulcer drugs, and the enlargement of personalized medicine strategies in ulcer therapy.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Industry Forces Are Driving The Gastric Ulcers Market Forward?

Anticipated growth in the gastric ulcers market is linked to the rising geriatric population. This demographic generally includes individuals aged 65 years and above, who are distinguished by unique health concerns associated with old age. An upsurge in this aging population results from advancements in healthcare that lead to increased life expectancy and falling birth rates in numerous global regions. Gastric ulcers are prevalent among senior citizens due to their frequent use of NSAIDs and reduced mucosal protective capabilities, often leading to elevated risk of complications. For example, data from the Population Reference Bureau (PRB), a private non-profit organization based in the US, states that in January 2024, the American population of people aged 65 and above is projected to rise from 58 million in 2022 to 82 million by 2050, demonstrating a 47% increase. Furthermore, the estimations anticipate the rise of this demographic’s distribution in the overall population from 17% to 23%. Such an increase designates a substantial age trend within the American populace. These statistics emphasize the escalating significance of catering to older adults’ requirements across various sectors. Consequently, this rise in the geriatric population is stimulating the growth of the gastric ulcers market.

How Is The Gastric Ulcers Market Organized By Different Segments?

The gastric ulcersmarket covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes

2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis

3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole; Lansoprazole; Pantoprazole; Esomeprazole; Rabeprazole

2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine

3) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide; Sodium Bicarbonate

4) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline

5) By Cytoprotective Agents: Sucralfate; Misoprostol; Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues; Prokinetic Agents; Herbal And Alternative Medications; Combination Therapies

What Current And Upcoming Trends Are Shaping The Gastric Ulcers Market?

Key players in the gastric ulcer marketplace are channeling their efforts towards creating novel products like unique drug formulations to boost treatment efficiency and minimize adverse effects. New formatted medicines pertain to drugs that are innovatively combined with active compounds, delivery methodologies, or dosage formats to augment their efficiency, safety, and patient adherence. For illustration, in June 2024, an Indian pharmaceutical preparation manufacture firm, Akums Drugs and Pharmaceuticals Ltd. introduced Rabeprazole + Levosulpiride SR Capsules to offer increased alleviation for ailments such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products blend a proton pump inhibitor with a prokinetic agent, adeptly tackling gastrointestinal diseases like GERD and gastric ulcers. This concoction not only curtails gastric acid secretion but also ameliorates gastric motility, affording extensive relief from symptoms like heartburn and upset stomach.

Who Are The Primary Market Leaders In The Gastric Ulcers Market?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

How Do Regional Dynamics Influence The Gastric Ulcers Market Performance?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model